skip to content

eLesor Investments version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 697.5 99.8" style="enable-background:new 0 0 697.5 99.8;" xml:space="preserve" aria-labelledby="title--mwlogoHeader desc--mwlogoHeader" role="img"> eLesor Site Logo A link that brings you back to the homepage.

Company Close Updates

Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

Company Logo

Terrence Horan

Referenced Symbols

Shares of Vertex Pharmaceuticals Inc. VRTX, -2.04% plunged 10.96% to $193.02 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, -0.22% rising 0.19% to 4,247.44 and the Dow Jones Industrial Average DJIA, -0.39% rising 0.04% to 34,479.60. The stock's fall snapped a three-day winning streak. Vertex Pharmaceuticals Inc. closed $113.06 below its 52-week high ($306.08), which the company reached on July 7th.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson JNJ, -0.13% fell 1.27% to $164.96, Merck & Co. Inc. MRK, -0.13% rose 0.17% to $76.27, and AbbVie Inc. ABBV, +0.04% fell 0.71% to $115.42. Trading volume (13.7 M) eclipsed its 50-day average volume of 1.6 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Partner Center